Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 104 results for "glenmark generics inc"

Glenmark Generics receives ANDA approval for Levonorgestrel, Ethinyl Estradiol Tablets
India Infoline

Glenmark Pharmaceuticals receives ANDA approval for Levonorges...

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (US FDA) for the extended-cycle oral contraceptive, Levonorgestrel/ Ethinyl Estradiol Tablets USP, 0.15 mg/ 0.03 mg, the AB rated ... HDFC Securities, 2 weeks ago
Glenmark ships Dovonex generic Chain Drug Review, 3 weeks ago

3 images for "glenmark generics inc"

India Infoline, 2 months ago
San Antonio Business Journal, 2 months ago
San Antonio Business Journal, 2 months ago
Money Control

Glenmark gets tentative FDA nod for generic psoriasis cream

Glenmark will market the product upon receiving final approval of its Calcipotriene cream, 0.005% abbreviated new drug application, the company said. New Delhi: Glenmark Pharmaceuticals has received tentative approval from the US health regulator ...
 Livemint.com1 month ago Glenmark Pharma gets ANDA nod for Desmopressin Acetate Tablets  MyIris1 month ago Glenmark gets tentative USFDA nod for generic psoriasis cream  Hindu Business Line1 month ago Glenmark gets tentativenod for psoriasis cream  ZeeNews.com1 month ago

Glenmark's US arm to pay $25 million fine for inflating drug prices

Glenmark Pharmaceuticals on Wednesday said its US-based subsidiary Glenmark Generics Inc has agreed to settle the pricing investigation with the Texas Attorney General under the Texas Medicaid Fraud Prevention Act (TMFPA) by paying $25 million (around Rs 155 ...
 DNA2 months ago Glenmark Pharmaceuticals: Updates on subsidiary company  Money Control2 months ago Glenmark Pharmaceuticals updates on subsidiary  Business Standard2 months ago

Eisai and Glenmark Reach Settlement over Generic Version of BANZEL® (rufinamide)

/PRNewswire/ --Eisai Inc. and Eisai Co., Ltd. have entered into a settlement agreement with Glenmark Pharmaceuticals, Ltd., Glenmark Generics Ltd., and Glenmark Generics, Inc.,USA("Glenmark"), to resolve their patent litigation relating to Eisai's ...
 FierceBiotech1 month ago Eisai Inc. And Glenmark Pharmaceuticals Reach Settlement Over Generic Version Of BANZEL (rufinamide)  BioSpace2 months ago

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Jun. 30, 2015 8:21 AM ET | About: AbbVie Inc. (ABBV), Includes: GILD, GSK, JUNO, SRPT by: Kanak Kanti De Summary In today's news, Celgene and Juno sign collaboration agreement. AbbVie's prescription volume increases, Gilead's falls. ...
 Seeking Alpha3 days ago
NDTV Profit

Glenmark Pharmaceuticals Gains Post Oral Contraceptive Nod

Glenmark Pharmaceuticals gained nearly 2 per cent to Rs 895 on Monday, after it informed the stock exchanges that it had received the US drug regulator's approval for an extended-cycle oral contraceptive. Glenmark Pharmaceuticals informed the ...
 NDTV Profit2 weeks ago Glenmark Pharma gains after USFDA approval for oral contraceptive drug  Capital Market2 weeks ago Glenmark Pharma gains on USFDA nod for oral contraceptive drug  Business Standard India2 weeks ago Glenmark Pharma gets USFDA nod for oral contraceptives  The Financial Chronicle2 months ago

Glenmark Pharma's net drops by over 75% in Q4, final dividend of 200%

Glenmark Pharmaceuticals has suffered heavy setback during the fourth quarter ended March 2015 and its consolidated net profit declined sharply by 75.4 per cent to Rs. 10.61 crore from Rs. 43.07 crore in the corresponding period of last year mainly ...
 PharmaBiz1 month ago Glenmark Pharmaceuticals reports Q4 net profit at Rs 10.61 crore  Economic Times1 month ago Glenmark Q4 profit plunges 75% to Rs 10 crore on one-time legal charges  Livemint.com1 month ago Glenmark Pharma Posts Profit of Rs 10 Cr in Q4  NDTV Profit1 month ago

Glenmark's subsidiary to pay $25m to settle a pricing case

Pharmaceutical major Glenmark today said its US subsidiary will pay $25 million to the federal government there as well as to the Texas state administration to settle a pricing investigation. The company will pay $11.25 million each to the US federal ...
 The Financial Chronicle2 months ago Glenmark's subsidiary to pay USD 25 million to settle a pricing case  Jagran Post2 months ago

Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies

/PRNewswire/ -- Dermatological drugs - new study showing you trends, partnerships, and predicted revenues Where is the market for dermatological drugs heading? What are the commercial prospects for this market? Visiongain's new report shows you ...
 TickerTech.com4 days ago

Global markets remain depressed

Posted by Equitymaster Majority of the markets, barring a few including India and the US, witnessed downfall in the week gone by. The Chinese index saw the steepest correction of 13.3% since 2008 on concerns of strict trading rules as well a string of IPO s ...
 Equitymaster.com1 week ago Global Erectile Dysfunction Drugs Market to Grow at 4% CAGR to 2018  TickerTech.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less